This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Nitsue Notake: Innovator in Biotechnology
Introduction
Nitsue Notake is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of genetic engineering. His work focuses on the development of novel polypeptides and their applications in medicine.
Latest Patents
Nitsue Notake holds a patent for a groundbreaking invention titled "DNA encoding rabbit TNE, vector having said DNA inserted thereinto, host." This patent describes a novel cloned DNA encoding a rabbit Tumor Necrosis Factor (TNF) or a principal portion thereof. The invention includes a vector that has this DNA inserted into it, a host transformed with the vector, and a process for producing the polypeptide by cultivating the transformed host. He has 1 patent to his name.
Career Highlights
Nitsue Notake is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to advance his research in biotechnology. His innovative work has the potential to impact therapeutic approaches in treating various diseases.
Collaborations
Throughout his career, Nitsue has collaborated with notable colleagues, including Masaaki Yamada and Yasuji Furutani. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.
Conclusion
Nitsue Notake is a distinguished inventor whose work in biotechnology exemplifies innovation and dedication. His contributions, particularly in the field of genetic engineering, are paving the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
